Quick Links

Contact Us

Publications:

Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with

Authors: Robert P Cowan|||Noah B Gross|||Melanie D Sweeney|||Abhay P Sagare|||Axel Montagne|||Xianghong Arakaki|||Alfred N Fonteh|||Berislav V Zlokovic|||Janice M Pogoda|||Michael G Harrington

Journal: Headache

Publication Type: Journal Article

Date: 2021

DOI: NIHMS1684323

ID: 33724462

Affiliations:

Affiliations

    Department of Neurology, Stanford University, Palo Alto, CA, USA.|||Neurosciences, Huntington Medical Research Institutes, Pasadena, CA, USA.|||Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.|||Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.|||Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.|||Neurosciences, Huntington Medical Research Institutes, Pasadena, CA, USA.|||Neurosciences, Huntington Medical Research Institutes, Pasadena, CA, USA.|||Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.|||Cipher Biostatistics & Reporting, Reno, NV, USA.|||Neurosciences, Huntington Medical Research Institutes, Pasadena, CA, USA.

Abstract

Our objective is to explore whether blood-cerebrospinal fluid (CSF) barrier biomarkers differ in episodic migraine (EM) or chronic migraine (CM) from controls.

Chemical List

    Biomarkers|||Vascular Cell Adhesion Molecule-1|||Fibrinogen

Reference List

    J Neurosci. 2010 Jun 30;30(26):8807-14|||Eur J Immunol. 1998 Mar;28(3):995-1004|||Headache. 2001 Jul-Aug;41(7):629-37|||Acta Neuropathol. 2018 Mar;135(3):337-361|||Coll Antropol. 2008 Jan;32 Suppl 1:99-103|||Headache. 2018 Apr;58(4):496-505|||Pain. 2007 Jul;130(1-2):166-76|||PLoS One. 2015 Jun 04;10(6):e0128870|||Headache. 2008 Jan;48(1):135-9|||Am J Pathol. 1996 Jun;148(6):1819-38|||Neurol Clin. 2019 Nov;37(4):631-649|||Neuron. 2015 Jan 21;85(2):296-302|||Headache. 2010 Mar;50(3):459-78|||Nat Genet. 2016 Aug;48(8):856-66|||Brain. 2017 Jun 1;140(6):1633-1642|||Neuron. 2018 Sep 5;99(5):1098|||Mult Scler. 2016 May;22(6):770-81|||Brain Res. 2015 Mar 10;1600:93-109|||Nat Med. 2019 Feb;25(2):270-276|||J Clin Invest. 2004 May;113(10):1447-55|||Trends Immunol. 2012 Dec;33(12):579-89|||Fluids Barriers CNS. 2020 May 6;17(1):35|||Brain. 2016 Jul;139(Pt 7):1994-2001|||Rev Neurol (Paris). 2005 Jul;161(6-7):655-7|||Nat Neurosci. 2016 May 26;19(6):771-83|||Neuron. 2018 Mar 7;97(5):1004-1021|||Physiol Rev. 2019 Jan 1;99(1):21-78|||Cephalalgia. 2007 Oct;27(10):1166-70|||Ann Neurol. 2020 Jun;87(6):939-949|||Immunity. 2013 Mar 21;38(3):555-69|||Physiol Rev. 2017 Apr;97(2):553-622|||Sci Rep. 2015 Jun 17;5:11412|||Cephalalgia. 2011 Mar;31(4):456-62|||Eur J Neurol. 2017 Sep;24(9):1116-1124|||Brain. 2016 Jul;139(Pt 7):1987-93|||Nat Rev Immunol. 2012 Sep;12(9):623-35|||J Cereb Blood Flow Metab. 1985 Sep;5(3):350-7|||Cephalalgia. 2013 Jul;33(9):629-808|||Nat Med. 2019 Jun;25(6):988-1000|||Headache. 2006 Jul-Aug;46(7):1128-35|||Neurology. 2005 Jun 28;64(12):2145-7|||Cephalalgia. 2011 Sep;31(12):1254-65